RESIST-TB Webinar: Panel on Long-Acting Injectables for TB Treatment

21 September 2025

RESIST-TB will host a webinar on 2 October 2025 on long-acting injectables for TB treatment.

Join the webinar to hear about this possible game-changing innovation for TB with the following guest speakers:

• Erin McConnell from Treatment Action Group – presenting ongoing work regarding acceptability & preferences and closing existing gaps to support roll out.
• Charles Wells from Gates Medical Research Institute – presenting results from a discrete-choice experiment pilot study and the next phases of work on preference.
• Eric Nuermberger from Johns Hopkins University – presenting on the science of long-acting injectables for TB prevention.

Register for the event here.

Source: RESIST-TB